AI assistant
Sending…
Oramed Pharmaceuticals Inc. — Board/Management Information 2017
Jul 23, 2017
6965_rns_2017-07-23_b40d57b8-4f3c-450e-874c-f2e049058398.htm
Board/Management Information
Open in viewerOpens in your device viewer
_________ false
| ����� ����������� ���� | 2 359 |
| ORAMED PHARMACEUTICALS INC | |
| Corporation no: 980376008 | 11653 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C304 ( Public ) | Reported via MAGNA: | 23/07/2017 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2017-02-063331 | Time of broadcast: 17:38 17:37:51 |
Initial Details relating to Directors and Senior Management
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto are the details of the directors and senior management as of the 12/07/2017 D_Os_isa.pdf
Explanation: the details should be as stated in the last 20-F or if the corporation has published updated information since, then those details should be given.
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: -1 | Date of revision of form structure: 16/07/2017 |
| Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390 , Israel Tel: 02-5660001 , 02-5788763 Fax: 02-5660004 | |
| E-mail address: [email protected] Company site: www.ermed.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: ZOMMER YIFAT HEN Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company: .Oramed Ltd | |
| Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390 Telephone: 02-5788763 Facsimile: 02-5660004 E-mail: [email protected] 2 | |
| Israel |
More from Oramed Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 20
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2026
Jan 29